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ABSTRACT
The SRS2 (Suppressor of RAD Six screen mutant 2)
gene encodes an ATP-dependent DNA helicase
that regulates homologous recombination in
Saccharomyces cerevisiae. Mutations in SRS2
result in a hyper-recombination phenotype, sensi-
tivity to DNA damaging agents and synthetic
lethality with mutations that affect DNA metabolism.
Several of these phenotypes can be suppressed by
inactivating genes of the RAD52 epistasis group that
promote homologous recombination, implicating
inappropriate recombination as the underlying
cause of the mutant phenotype. Consistent with
the genetic data, purified Srs2 strongly inhibits
Rad51-mediated recombination reactions by dis-
rupting the Rad51-ssDNA presynaptic filament.
Srs2 interacts with Rad51 in the yeast two-hybrid
assay and also in vitro. To investigate the functional
relevance of the Srs2-Rad51 complex, we have
generated srs2 truncation mutants that retain full
ATPase and helicase activities, but differ in their
ability to interact with Rad51. Importantly, the srs2
mutant proteins attenuated for Rad51 interaction
are much less capable of Rad51 presynaptic
filament disruption. An internal deletion in Srs2
likewise diminishes Rad51 interaction and anti-
recombinase activity. We also present evidence
that deleting the Srs2 C-terminus engenders a
hyper-recombination phenotype. These results
highlight the importance of Rad51 interaction in
the anti-recombinase function of Srs2, and provide
evidence that this Srs2 function can be uncoupled
from its helicase activity.
INTRODUCTION
Homologous recombination (HR) is a major pathway for
the elimination of DNA double-strand breaks (DSBs)
induced by genotoxic agents or that arise from
endogenous damage and replication fork demise. As
such, HR is critical for maintaining genome integrity
and important for cancer avoidance in humans (1–3).
Paradoxically, intermediates generated by the HR
machinery can trigger prolonged arrest of the cell cycle
(4), and the aberrant resolution of these intermediates
can lead to gross chromosomal rearrangements, such as
translocations (5,6). Moreover, the HR machinery can
interfere with other DNA repair pathways, such as
RAD6/RAD18-mediated post-replicative repair (PRR)
(4,7). For these reasons, cells possess multiple mechanisms
to prevent untimely and deleterious HR events. One such
mechanism is mediated by the SRS2 (Suppressor of RAD
Six screen mutant 2) gene in Saccharomyces cerevisiae.
A mutant variant of SRS2 was ﬁrst recognized as a
suppressor of the DNA damage sensitivity of rad6 or
rad18 mutants (8). Suppression of the rad6 or rad18
DNA repair defect by the srs2 mutation requires that
HR be functional (9), suggesting that SRS2 negatively
regulates HR. By attenuating HR, it is thought that
SRS2 helps ensure the channeling of DNA lesions encoun-
tered by the DNA replication machinery into the
Rad6/Rad18-mediated PRR pathway. Yeast strains
harboring certain SRS2 mutations also exhibit a
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DNA damage checkpoint-mediated G2/M arrest, and syn-
thetic lethality with a variety of other mutations, such as
sgs1, that aﬀect DNA metabolism (10). The synthetic
lethality of these double mutants often can be overcome
by eliminating HR (11,12), implicating inappropriate HR
events as the cause of lethality.
As a member of the SF1 family of nucleic acid unwind-
ing enzymes (13), Srs2 possesses ssDNA-dependent
ATPase and DNA helicase activities (14,15). In concor-
dance with the genetic data, Srs2 strongly inhibits the for-
mation of DNA joints in in vitro recombination reactions
that are mediated by the Rad51 recombinase (16,17).
Extensive biochemical and electron microscopic analyses
have shown that Srs2 accomplishes this feat by disrupting
the Rad51 presynaptic ﬁlament, comprised of a right-
handed Rad51 helical polymer assembled on ssDNA
(16,17), that catalyzes recombination reactions (18).
The Rad51 presynaptic ﬁlament dissociative function
and HR attenuating role of Srs2 require its ATPase
activity (19). Srs2 interacts with the sumoylated form of
the proliferating cell nuclear antigen (PCNA) at DNA
replication forks (20,21). This serves to target Srs2 to
DNA replication forks to prevent Rad51 presynaptic
ﬁlament assembly, thereby avoiding unwanted recombina-
tion during DNA replication (20,21). Interestingly, when
PCNA is not able to be sumoylated, Srs2 recruitment to
S phase replication fork foci is decreased, while its
recruitment to recombination foci is unaﬀected (22).
This reveals that recruitment of Srs2 to replication forks
or sites of recombination are independent processes.
Interestingly, even though Srs2 suppresses spontaneous
recombination events, it facilitates DSB repair by the
synthesis-dependent single-strand annealing (SDSA)
pathway of HR (23–25). In addition to its DSB repair
function, Srs2 has been shown to have a role in DNA
damage checkpoint activation during S phase (26) and
to act with DNA polymerase d to suppress DNA triplet
repeat expansion, possibly by unwinding DNA stem-loop
structures formed by the repeats (27,28).
By yeast two hybrid and biochemical analyses, Srs2 was
found to physically interact with Rad51 (16). However,
the signiﬁcance of the Rad51-Srs2 complex with regards
to the anti-recombinase function of Srs2 is not clear. Here,
we ﬁnely map the Rad51 interaction domain in Srs2
and generate mutant srs2 forms that retain ATP hydro-
lysis and helicase activities, but diﬀer in their ability
to interact with Rad51. We show that the Rad51
interaction-deﬁcient mutant srs2 proteins are attenuated
for the Rad51 presynaptic ﬁlament dissociative
function. Our results thus reveal a requirement for
complex formation with Rad51 in the anti-recombinase
function of Srs2.
MATERIALS AND METHODS
Yeast two-hybrid assay
RAD51 was fused to the GAL4 transcription activa-
tion domain in the vector pGAD10, and a C-terminal
SRS2 fragment encompassing residues 783–1174
harboring the Rad51 interaction domain (16) was fused
to the GAL4 DNA-binding domain in pGBKT7.
The pGAD10-RAD51 and pGBKT7-srs2 plasmids were
introduced into haploid yeast strains PJ69-4a (MATa
trp1-901 leu2-3,112 ura3-52 his3-200 gal4D gal80D
LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ) and
PJ69-4a (MAT  trp1-901 leu2-3,112 ura3-52 his3-200
gal4D gal80D LYS2::GAL1-HIS3 GAL2-ADE2
met2::GAL7-lacZ), respectively (29,30). Diploid strains
obtained by mating plasmid-bearing PJ69-4a and PJ69-
4a haploids were grown on synthetic medium lacking
tryptophan and leucine (30). To select for two-hybrid
interactions, which would result in the activation of the
ADE2 or HIS3 reporter genes, diploid cells were replica-
plated on synthetic medium lacking tryptophan, leucine
and adenine, or on synthetic medium lacking tryptophan,
leucine and histidine, respectively. Both plating gave the
same results. Only the plating on the tryptophan, leucine
and adenine dropout medium is shown in Figure 1A.
Additional pGBKT7-based plasmids containing Srs2
residues 783–998, 783–914 and 783–862 were also tested
for interaction with Rad51.
Plasmid construction
The pET11c-(His)9-SRS2 plasmid was generated by site-
directed mutagenesis (Stratagene) of pET11c-SRS2,
resulting in the addition of an N-terminal 9-histidine tag
to the open reading frame of Srs2 (21). The srs2 variants
were generated by site-directed mutagenesis (Stratagene)
using the pET11c-(His)9-SRS2 plasmid as template. The
srs2 783–998 and srs2 783–1174 cloned in pGBKT7 were
described elsewhere (16). The other two constructs, srs2
783–862 and srs2 783–914 in pGBKT7 were generated by
site-directed mutagenic insertion of a stop codon in srs2
783–998/pGBKT7.
Protein puriﬁcation
The puriﬁcation of the (His)9-tagged Srs2 and mutant srs2
proteins from Escherichia coli cells (50g of cell paste, from
10L of culture) was conducted as previously described
(15), except that an aﬃnity step on nickel NTA agarose
was included to exploit the (His)9 tag. Peak fractions from
the SP Sepharose column were combined and incubated
with 2ml of nickel-NTA agarose (Qiagen) for 2h at 4 C
with gentle mixing. The beads were washed with 50ml of
K buﬀer (20mM K2HPO4, pH 7.4, 10% glycerol, 0.5mM
DTT and 0.5mM EDTA) containing 300mM KCl and
10mM imidazole. Srs2 or mutant was eluted with 12ml
(8 fractions of 1.5ml each) of 300mM imidazole in K
buﬀer containing 300mM KCl. The peak fractions were
diluted with 2.5 volumes of T buﬀer (20mM Tris–HCl, pH
7.5, 10% glycerol, 0.5mM DTT and 0.5mM EDTA),
before being fractionated in a 1ml Mono S column, as
described (16). The nearly homogeneous Srs2 and
mutant protein preparations were concentrated to
 5mg/ml and stored in small aliquots at  80 C.
Rad51 and RPA were over-expressed in yeast and
puriﬁed to near homogeneity, as described (31). Rad54
and PCNA were expressed in E. coli and puriﬁed to
near homogeneity, as described (32,33).
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The DNA helicase substrate was constructed using
the unlabeled H3 oligonucleotide and
32P-labeled H1
oligonucleotide, as previously described (15). The fX174
(+) strand DNA was purchased from New England
Biolabs. The D1 oligonucleotide used in the D-loop
assay and the 150-mer E oligonucleotide used in electron
microscopy have been described (16,34).
Aﬃnity pulldown assays
Aﬃ-gel 15 beads containing Rad51 (Aﬃ-Rad51; 5mg/ml)
and bovine serum albumin (Aﬃ-BSA; 12mg/ml) were
prepared as described previously (35). (His)9-tagged Srs2
or the indicated mutant variant (5mg) was incubated with
5ml of Aﬃ-Rad51 or Aﬃ-BSA in 30ml of K buﬀer (20mM
K2HPO4, 10% glycerol, 0.5mM EDTA, 0.01% Igepal and
1mM DTT) containing 150mM KCl for 1hr on ice, with
gentle mixing. The beads were washed twice with 150mlo f
the same buﬀer before being treated with 30ml of 2% SDS
to elute the bound protein. The supernatant that
contained unbound Srs2 or mutant, the second wash,
and the SDS eluate, 10ml of each, were analyzed by
7.5% SDS-PAGE and staining with Coomassie Blue.
For the pull-down with srs2 875–902 and Rad51,
puriﬁed (His)9-tagged Srs2 or srs2 875–902 (5mg) was
mixed with puriﬁed Rad51 (5mg) in buﬀer K containing
150mM KCl for 1hr on ice, before adding 10ml Ni-NTA
agarose beads (Qiagen) and continuing the incubation for
30min on ice with gentle mixing. The beads were washed
twice with 150ml of the same buﬀer before being treated
with 30ml of 2% SDS to elute the bound protein.
The supernatant that contained unbound proteins, the
second wash and the SDS eluate, 10ml each, were
analyzed by 7.5% SDS-PAGE and staining with
Coomassie Blue. For examining Srs2-PCNA complex for-
mation, nickel pull-downs were conducted as described
above for srs2 875–902 and Rad51, however puriﬁed
PCNA (5mg) was used in place of Rad51.
ATPase assay
Puriﬁed Srs2 or truncated srs2 (35nM) was incubated with
1mM (g-
32P) ATP and fX174 (+) strand DNA (25mM
nucleotides) in 10ml of buﬀer A (30mM Tris–HCl, pH 7.5,
2.5mM MgCl2, 1mM DTT, 150mM KCl and 100mg/ml
BSA) for 7.5min at 37 C. The level of ATP hydrolysis was
determined by thin layer chromatography with phos-
phorimaging analysis in a Personal Molecular Imager
FX (Bio-Rad), as described (35).
DNA helicase assay
Puriﬁed Srs2 or mutant srs2 (40nM) was incubated at
30 C for 5min with the helicase substrate (300nM
nucleotides) in 10ml of buﬀer H (30mM Tris–HCl, pH
7.5, 2.5mM MgCl2, 1mM DTT, 100mM KCl, 2mM
ATP and 100mg/ml BSA). The reaction mixtures were
stopped, deproteinized and resolved in a 10% non-
denaturing polyacrylamide gel run in TAE buﬀer
(40mM Tris–HCl, pH 7.4, 0.5mM EDTA) at 4 C.
The gel was dried onto Whatman DE81 paper and sub-
jected to phosphorimaging analysis.
D-loop reaction
Reactions were carried out in Buﬀer D (35mM Tris–HCl,
pH 7.5, 2mM ATP, 2.5mM MgCl2, 1mM DTT,
including an ATP-regenerating system consisting of
20mM creatine phosphate and 20mg/ml creatine kinase)
and 50, 100 or 150mM KCl in a ﬁnal volume of 12.5ml, as
described previously (16). The
32P-labeled D1
oligonucleotide (3mM nucleotides) was incubated with
Rad51 (1mM) for 5min at 37 C to assemble the Rad51-
ssDNA nucleoprotein ﬁlaments, followed by the incorpo-
ration of RPA (200nM) and a 4min incubation. Then,
Rad54 (150nM) was added, and following a 3min incu-
bation at 23 C, the reaction was initiated by adding
pBluescript replicative form I DNA (50mM base pairs),
followed by a 6min incubation at 30 C. The reaction
was stopped by treatment with SDS (0.5%) and proteinase
K (0.5mg/ml) at 37 C for 5min and resolved in a 1%
agarose gel in TAE buﬀer. The gel was dried and subjected
to phosphorimaging analysis. The percentage D-loop
refers to the quantity of the D1 oligonucleotide substrate
that has been converted into D-loop. When present, Srs2
or mutant srs2 (7.5 or 15nM, as indicated) was added to
the reaction with RPA.
DNA strand exchange reaction
Reactions were conducted at 37 C in Buﬀer R (35mM
Tris–HCl, pH 7.4, 2mM ATP, 2.5mM MgCl2,5 0 m M
KCl, 1mM DTT and an ATP-regenerating system) in a
ﬁnal volume of 12.5ml, as described previously (36).
Rad51 (10mM) was incubated with fX174 circular (+)
strand (30mM nucleotides) for 4min, followed by a
6min incubation with RPA (2mM). The reaction was
completed by adding spermidine hydrochloride (4mM)
and linear fX dsDNA (30mM nucleotides). After an
80min incubation, the reaction mixtures were depro-
teinized and resolved in 0.9% agarose gels, followed by
ethidium bromide staining of the DNA species. When
present, Srs2 or srs2 mutant (30–60nM, as indicated)
was added to the reaction with RPA.
Topoisomerase I-linked assay
Reactions were carried out in 10ml of Buﬀer R at 37 C.
Rad51 (4mM) was incubated for 5min with fX174
circular (+) strand DNA (20mM nucleotides). Srs2 or
mutant srs2 (60 or 80nM, as indicated) and RPA (1mM)
were added, followed by a 4min incubation. Topologically
relaxed fX174 DNA (12.5mM nucleotides) and 2.5U calf
thymus topoisomerase I (Invitrogen) were then incorpo-
rated to complete the reaction. After 8min of incubation,
the reaction mixtures were deproteinized and then subject
to electrophoresis in 0.9% agarose gels. The DNA species
were stained with ethidium bromide.
Electron microscopy
Reaction mixtures were assembled as described for the
DNA strand exchange reaction except that the 150-mer
6756 Nucleic Acids Research, 2009,Vol.37, No. 20E oligonucleotide (34) (7.2mM nucleotides), Rad51
(2.4mM), RPA (0.5mM), Srs2 or mutant srs2 (100nM)
were used. After a 3min incubation, the reaction
mixtures were diluted 10 times with buﬀer R lacking the
ATP regenerating system, and a 3ml aliquot was applied
to 400-mesh grids coated with carbon ﬁlm and which had
been glow-discharged in air. The grids were stained with
2% uranyl acetate for 30sec and rinsed with water before
being examined with a Tecnai 12 Biotwin electron micro-
scope (FEI company) equipped with a tungsten ﬁlament at
100keV. Digital images were captured with a Morada
(Olympus Soft Imaging Solutions) charge-coupled device
camera at a nominal magniﬁcation of 87000X.
Yeast strains
All yeast strains were in the W303 background (leu2-3, 112
his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 RAD5). All
constructs were veriﬁed by DNA sequencing. The strains
were: HKY2070-4 (srs2 1–860), HKY2082-4 (srs2 D875–
902), HKY590-1D (srs2D), HKY579-10A (SRS2), and
F28-1A (rad18D).
Methyl methane sulfonate sensitivity
Methyl methane sulfonate (MMS) sensitivity was deter-
mined using freshly made plates containing 0.005%
MMS. Overnight cultures of strains were serially diluted
and 4ml aliquots of each dilution were applied onto YPD
and YPD+MMS plates. Growth was assessed after
2 and 3 days at 30 C. The rad18D strain used has been
described (37).
Determination of recombination rates
Recombination rates were calculated by the median
method of Lea and Coulson (38) using the leu2-
ecoRI::URA3::leu2-bstEII recombination system as
described previously (39). Three diﬀerent strains derived
from the same parental strains were analyzed for each
genotype studied. For each strain, nine independent
colonies were analyzed for each ﬂuctuation test.
RESULTS
Mapping the Srs2-Rad51 interaction in the yeast
two-hybrid assay
In previously published work, we and others
demonstrated an interaction between Rad51 and the
carboxy-terminal region of Srs2 in the yeast two-hybrid
assay, such that Srs2 fragments encompassing residues
783–1174 or residues 783–998 are capable of Rad51 asso-
ciation (16,40) (Figure 1A). Based on these two-hybrid
data, additional constructs harboring two other portions
of the Srs2 C-terminus were created and tested for Rad51
interaction. As shown in Figure 1A, while the 783–914
fragment showed robust interaction with Rad51, no
signal could be detected with the 783–862 fragment
(Figure 1A). Based on these results, we suspected the
Rad51 interaction domain in Srs2 to lie between amino
acid residues 862 and 914.
C-terminally truncated variants of Srs2 deﬁcient for
Rad51 interaction
To verify the yeast two-hybrid data in vitro and for
additional biochemical analyses, we constructed various
C-terminally truncated Srs2 variants—1–998, 1–910,
1–890, 1–875 and 1–860—by introducing stop codons
within the pET11c-(His)9-SRS2 plasmid. The tagged full
length Srs2 and the truncated variants were expressed in
E. coli by the use of the IPTG-inducible T7 promoter. The
chromatographic procedure for puriﬁcation of the (His)9-
tagged proteins was modiﬁed from the original protocol
(16) to include a nickel aﬃnity step. By this method, we
were able to purify full length Srs2 and the truncated srs2
variants to near homogeneity (Figure 1C).
To test for interaction with Rad51, puriﬁed Srs2 and the
ﬁve srs2 truncation mutant proteins were each mixed with
Aﬃ-gel beads that contained covalently conjugated
Rad51 protein (Aﬃ-Rad51) or bovine serum albumin
(Aﬃ-BSA). The beads were washed with buﬀer before
being treated with SDS to elute the bound Srs2 or srs2
Figure 1. Two-hybrid interactions of Rad51 with Srs2. (A) Fragments
of Srs2 were tested for two-hybrid interaction with Rad51 by plating on
medium lacking leucine, tryptophan and adenine. The empty vector
(pGBKT7) and plasmid harboring RAD52 were included as negative
and positive controls, respectively. (B) A schematic of the helicase and
protein-protein interaction domains in Srs2. (C) Puriﬁed Srs2, srs2
1–998, srs2 1–910, srs2 1–860, srs2 1–890 and srs2 1–875, 1mg each,
were analyzed by SDS-PAGE and stained with Coomassie Blue.
Nucleic Acids Research, 2009,Vol.37, No. 20 6757mutant protein, followed by SDS-PAGE analysis.
Consistent with results from the yeast two-hybrid
analysis, full length Srs2, srs2 1–998, and srs2 1–910
were retained on the Aﬃ-Rad51 beads but not on the
Aﬃ-BSA beads (Figure 2A and B). Importantly, and
consistent with the yeast two-hybrid results, srs2 1–860
did not bind the Aﬃ-Rad51 beads (Figure 2A), indicating
that it is defective for Rad51 interaction. Moreover, while
srs2 1–890 showed only a slightly attenuated aﬃnity for
Aﬃ-Rad51, little or no srs2 1–875 was retained on the
Aﬃ-Rad51 beads (Figure 2A). These results indicated
that the region between amino acid residues 875 and 910
in Srs2 is likely critical for Rad51 interaction.
Based on the above domain mapping results, we created
a form of Srs2 that lacks amino acid residues 875–902, but
is otherwise full length. The srs2 875–902 mutant was
expressed and puriﬁed to near homogeneity following the
strategy used for other Srs2 forms (Figure 2C, panel I) and
examined for interaction with Rad51. The internal
deletion mutant exhibited some non-speciﬁc binding to
Aﬃ-BSA beads, thus the pulldown analysis was conducted
using nickel NTA aﬃnity beads to isolate the protein
complex via the (His)9-tag on Srs2. Full-length Srs2 was
able to bind Rad51 as expected, but little or no Rad51
associated with srs2 875–902 (Figure 2C, panel II).
This provides evidence that the region between residues
875–902 of Srs2 is needed for Rad51 interaction.
Additionally, we tested the ability of the internal
deletion mutant to bind PCNA. The PCNA interaction
domain is known to lie in the far C-terminus of Srs2
(20,41), and consistent with this, we found that srs2
875–902 is just as adept as Srs2 in PCNA interaction
(Figure 2C, panel III).
C-terminal truncations do not aﬀect ATPase and
helicase activities
The deduced Rad51 interaction domain in Srs2 resides
distally to the catalytic domains that are concerned with
ATP hydrolysis and helicase activity (Figure 1B), so we
expected even the shortest of our srs2 truncation variants,
i.e. srs2 1–860, to retain the ability to hydrolyze ATP and
unwind DNA. To verify this expectation, the puriﬁed
srs2 mutant proteins were ﬁrst tested for their ability
to hydrolyze ATP. We showed previously that ATP
hydrolysis by Srs2 is ssDNA-dependent (15), and, as
summarized in Figure 3A, all of the srs2 truncation
variants show a level of ssDNA-dependent ATPase
activity comparable to that of the wild-type protein. We
next examined the various srs2 truncation mutant proteins
for DNA helicase activity using a
32P-labeled substrate
that contained a 40bp duplex region with a 40-nucleotide
30-ssDNA overhang [Figure 3B and (15)]. As shown in
Figure 3B, the srs2 mutants were as adept as the full
length Srs2 protein in unwinding the DNA substrate.
Based on the above results, we can conclude that all of
the truncated forms of srs2 that we have generated possess
ATP hydrolysis and DNA helicase activities comparable
to those of the wild-type counterpart.
Interaction of Srs2 with Rad51 is critical for its
anti-recombinase function
We (16) and others (17) demonstrated previously that
Srs2 inhibits the recombinase activity of Rad51 (42).
We used the D-loop assay to test the anti-recombinase
activity of our srs2 truncation mutants (Figure 4A).
Figure 2. Mapping of Rad51 interaction by in vitro pull-down assay.
Puriﬁed Srs2, srs2 1–998, srs2 1–910, srs2 1–890, srs2 1–875 and srs2
1–860 were mixed with Aﬃ-Rad51 beads (A) or Aﬃ-BSA beads
(B) The supernatant that contained unbound protein (S), wash (W)
and the SDS eluate (E) were resolved by SDS-PAGE and stained
with Coomassie Blue. (C) In panel I, Puriﬁed srs2 875–902, 1mg,
analyzed by SDS-PAGE and stained with Coomassie Blue. In panel
II, Srs2 and srs2 875–902 were combined with puriﬁed Rad51 and
mixed with nickel NTA agarose beads. The supernatant that contained
unbound protein (S), wash (W) and the SDS eluate (E) were resolved
by SDS-PAGE and stained with Coomassie Blue (lanes 1–6). As
control, Rad51 alone was incubated with nickel NTA agarose beads
(lanes 7–9). In panel III, Srs2 and srs2 875–902 were examined for
PCNA interaction (lanes 1–9) following the same procedure in panel II.
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of Srs2 (7.5–15nM) to the D-loop reaction containing
Rad51, Rad54 and the heterotrimeric ssDNA-binding
factor RPA led to pronounced inhibition of the reaction
(Figure 4B). The two srs2 truncation mutants, srs2 1–998
and srs2 1–910, that are able to interact with Rad51 also
inhibited the D-loop reaction to a comparable degree as
Srs2 (Figure 4B). However, the srs2 1–875 and srs2 1–860
mutants, which are deﬁcient in Rad51 interaction, exerted
only a slight inhibitory eﬀect on the D-loop reaction
(Figure 4B). The slight inhibition observed with increasing
amounts of srs2 1–875 or srs2 1–860 could be due to
a residual interaction with Rad51. Likewise, the srs2
875–902 mutant that is also deﬁcient in Rad51 interac-
tion is again signiﬁcantly impaired for the ability to
suppress the D-loop reaction (Figure 4C). Interestingly,
the srs2 1–890 truncation mutation that is partially
attenuated for Rad51 interaction showed an intermediate
level of inhibition of the D-loop reaction, with the defect
being much more obvious at higher concentrations of KCl
(Figure 4B, panel III), which very likely weakened the
residual interaction between Rad51 and this srs2 mutant.
Altogether, these results revealed interaction with Rad51
as important for the anti-recombinase activity of Srs2.
Examination of Rad51-interaction defective srs2 mutants
in the DNA strand exchange reaction
We applied a DNA strand exchange system that uses
plasmid length DNA substrates to seek independent veri-
ﬁcation that interaction with Rad51 is critical for the anti-
recombinase attribute of Srs2. In this system, Rad51-made
DNA joint molecules are processed by DNA strand
exchange to yield nicked circular duplex as the ﬁnal
reaction product (16,18) (Figure 5A). As expected (16),
the addition of a catalytic quantity of Srs2 (30 and
60nM) strongly suppressed the DNA strand exchange
reaction (Figure 5B). In contrast, little or no attenuation
of DNA strand exchange eﬃciency was seen when srs2
1–860 or srs2 875–902 was tested (Figure 5B). The
above results support our conclusion that the eﬃcacy of
Srs2’s anti-recombinase activity is contingent upon Rad51
interaction.
Relevance of protein–protein interaction in Rad51
presynaptic ﬁlament disruption
The above results obtained using C-terminally truncated
srs2 mutant proteins helped establish that interaction with
Rad51 is critical for Srs2’s ability to attenuate Rad51-
mediated HR homologous DNA pairing and strand
exchange. We employed a biochemical assay to provide
evidence that the impairment of anti-recombinase
activity in the truncated srs2 mutants stems from an
inability to disrupt the Rad51 presynaptic ﬁlament. In
this biochemical test, pre-assembled presynaptic ﬁlaments
are incubated with Srs2 or one of the srs2 mutants
together with RPA, and then topologically relaxed
duplex DNA is added to trap the Rad51 molecules freed
from ssDNA as a result of anti-recombinase function.
Since Rad51 binding induces lengthening of the DNA
trap, the level of anti-recombination function can be
conveniently monitored as a DNA linking number
change upon treatment of the duplex with topoisomerase
I [Figure 6A, (16)]. The product of this reaction, an
underwound DNA species called form U (Figure 6B,
lane 2), is resolved from other DNA species by agarose
gel electrophoresis and then revealed by ethidium bromide
staining.
As expected, the addition of Srs2 to the presynaptic
ﬁlaments led to the generation of form U, indicative of
the release of Rad51 from the ssDNA [Figure 6B, (15)].
Abundant Form U DNA was also seen when the Rad51
interaction proﬁcient srs2 1–910 mutant, which we
Figure 3. Proﬁciency of the srs2 mutants in ATP hydrolysis and DNA
unwinding. (A) Graphical representation of the ssDNA-dependent
ATPase activity of Srs2 and srs2 mutants. (B) The DNA helicase
activity of Srs2 and srs2 mutants was assayed using a 30-tailed duplex
substrate (panel I) and the results quantiﬁed (panel II). NP, no protein
control; HD, heat-denatured substrate. In all cases, error bars represent
the standard deviations derived from three independent experiments.
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recombinase activity (e.g. Figure 4B), was incubated
with the presynaptic ﬁlaments (Figure 6B). Importantly,
the Rad51-interaction deﬁcient srs2 1–860, srs2 1–875 and
srs2 875–902 mutants, which we found to be impaired
for anti-recombinase activity, were incapable of producing
a signiﬁcant amount of Form U DNA (Figure 6B). These
results thus provide direct evidence that dissociation of the
Rad51 presynaptic ﬁlament by Srs2 is reliant upon the
interaction between Srs2 and Rad51.
Analysis by electron microscopy
We also employed electron microscopy to examine and
quantify the disruption of Rad51 presynaptic ﬁlaments
by Srs2 and several of the srs2 truncation mutants. For
this purpose, we assembled Rad51 presynaptic ﬁlaments
on a 150-mer oligonucleotide (43) and then incubated
these ﬁlaments with Srs2 or one of several srs2 mutants
in conjunction with RPA. The reaction mixtures were
diluted with buﬀer, applied onto carbon grids, and then
examined by electron microscopy to quantify the levels of
Figure 4. Relevance of the Srs2-Rad51 complex in the attenuation of the D-loop reaction. (A) D-loop reaction scheme. (B) In panel I, the
radiolabeled D1 oligonucleotide was incubated with Rad51, Rad54, RPA (lanes 2–12) and with or without Srs2, srs2 1–998, srs2 1–910, srs2
1–875 or srs2 1–860 (7.5 or 15nM) and then pBluescript form I DNA was incorporated. The reaction (lane 2) without Srs2 or mutant srs2 is
designated as standard (Std) and corresponded to conversion of 43% of the input D1 oligonucleotide into the D-loop product. Lane 1 contained the
DNA substrates but no protein. The KCl concentration was 50mM KCl in these reactions and the results were quantiﬁed and plotted in panel II.
In panel III, the results from D-loop reactions carried out at 50, 100, and 150mM KCl with 15nM of Srs2 or srs2 mutant were quantiﬁed and
plotted. The D-loop product in the standard (Std) was 58%, 61% and 66% at 50, 100 and 150mM KCl, respectively. (C) Panel I shows D-loop
reactions with 7.5 and 15nM Srs2, srs2 875–902 or srs2 1–860 at 50mM KCl. The D-loop in the standard (Std) was 54%. The results were
quantiﬁed and plotted in panel II. In all cases, error bars represent the standard deviations derived from three independent experiments.
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each case. As summarized in Figure 7, Rad51 presynaptic
ﬁlaments accounted for  80% of the nucleoprotein
complexes in Srs2’s absence, whereas these ﬁlaments
represented only a little over 20% of the nucleoprotein
complexes upon the addition of Srs2. As we had
anticipated, srs2 1–910 was just as adept as the full-
length protein in Rad51 presynaptic ﬁlament dissociation,
but, importantly, srs2 1–875 or srs2 875–902 was much
less eﬀective in this regard (Figure 7). Overall, the results
from the EM analysis provided independent support for
Rad51 interaction as a key determinant in the eﬃcacy of
Srs2 as an anti-recombinase.
Phenotypic analysis of srs2 mutants
We wished to examine the genetic behavior of some of our
srs2 mutants. Yeast strains were created which lacked Srs2
(srs2D), or that lacked amino acid residues 861–1174 (the
1–860 allele) or 875–902 (the D875–902 allele) of Srs2.
As expected (8), the deletion of SRS2 suppressed the
DNA damage sensitivity of the rad18D mutation
(Figure 8A). DNA damage sensitivity of rad18D mutants
can be suppressed by nonfunctional srs2 mutations in
a RAD51-dependent manner (13). Suppression of the
rad18D MMS sensitivity was seen with the srs2 1–860
but not the srs2 D875–902 allele (Figure 8A).
We next examined the srs2 mutant strains for a hyper-
recombination phenotype. Consistent with published
results (10), we observed a 4-fold increase in the rate of
gene conversion events in srs2D cells (Figure 8B). A sim-
ilarly elevated gene conversion rate, one that was three-
fold that of wild-type (Figure 8B), was found for the srs2
1–860 mutant. In contrast, the srs2 D875–902 gave a gene
conversion rate that is only slightly higher than the wild-
type control (Figure 8B). These ﬁndings ﬁt with our
observations that the srs2 1–860 mutant protein is quite
defective in Rad51 interaction and in the inhibition
of Rad51-mediated reactions, while the srs2 875–902
mutant protein retains some ability to interact with
Rad51 and possesses residual anti-recombinase activity.
DISCUSSION
Despite the important contributions that HR makes to
the elimination of deleterious DNA lesions and the
re-establishment of injured DNA replication forks, it
must be tightly regulated so as to prevent untimely
Figure 5. Anti-recombinase activity examined by DNA strand
exchange. (A) The DNA strand exchange scheme. (B) In panel I,
circular fX174 (+) strand DNA was incubated with Rad51, RPA,
and in the absence or presence of Srs2, srs2 875–902 or srs2 1–860
(30 and 60nM), and then spermidine and linear fX dsDNA were
added and the reaction incubated for either 40 or 80min. A reaction
without Srs2 or mutant srs2, designated as standard (Std; lane 2) served
as a control. The DNA substrates were also incubated without any
protein (Bl; lane 1). Only the results from the 80min time-point are
shown. In panel II, the sum of joint molecules and nicked circular
duplex from the 40min and 80min time-points of reactions that
contained 30nM Srs2 or srs2 mutant was plotted. In all cases, error
bars represent the standard deviations derived from the results of three
independent experiments.
Figure 6. Rad51 presynaptic ﬁlament disruption as measured by a
topoisomerase-linked assay. (A) Reaction scheme for detecting Rad51
presynaptic ﬁlament disruption. (B) Rad51 presynaptic ﬁlaments were
incubated without or with Srs2, srs2 1–910, srs2 875–902, srs2 1–875
or srs2 1–860 (60 and 80nM) before the addition of relaxed DNA and
topoisomerase I (lanes 3–13). Lane 2 contains Form U DNA made by
incubating topologically relaxed DNA with Rad51 and topoisomerase
I. Lane 1 contains topologically relaxed DNA.
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repair processes, or to avoid the generation of toxic
nucleoprotein intermediates that trigger prolonged cell
cycle arrest (6,7,11,44). Moreover, crossover HR events
are disfavored in mitotic cells, as they can give rise to
undesirable chromosome rearrangements, such as
translocations. Genetic and other companion analyses
have found several pathways able to attenuate undesirable
HR events or promote the usage of the conservative
SDSA pathway that does not entail the generation of
crossovers. Importantly, all of these HR regulatory
pathways are dependent on a DNA helicase. Speciﬁcally,
the human BLM helicase, and likely its S. cerevisiae coun-
terpart Sgs1, functions with Topo IIIa (Top 3 in yeast), a
type 1A topoisomerase, and other associated factors to
resolve key HR DNA intermediates, such as the double
Holliday structure, to non-crossover recombinants in a
process termed double Holliday junction dissolution
(45). Interestingly, the Srs2 helicase suppresses spurious
HR events and also prevents crossover formation via a
unique ability to disrupt the Rad51 presynaptic ﬁlament
(16,17). Genetic and biochemical evidence has been pre-
sented to implicate the mammalian RECQ5 helicase in
HR regulation via the same general mechanism as Srs2
(43). More recently, a separate means of HR regulation has
been documented for the S. cerevisiae Mph1 helicase and
its orthologues human FANCM and Schizosaccharomyces
pombe Fml1; these orthologous helicases have been
suggested to promote the use of the SDSA pathway of
HR by disrupting the D-loop intermediate made by the
Rad51 recombinase protein (34,46). Finally, the human
RTEL1 helicase has also been shown to disrupt Rad51-
made D-loops, but this novel attribute of RETL1
is thought to exert a general suppressive eﬀect on HR
frequency rather than fulﬁlling a regulatory role.
Importantly, mutations in all the above helicases compro-
mise genome instability and in some cases are associated
with the tumor phenotype (43,47,48).
Several of the aforementioned helicases, including Srs2,
RECQ5 and BLM/Sgs1 are known to physically interact
with Rad51 (16,43,49), although the functional signiﬁ-
cance of these protein-protein interactions has not been
addressed. In this study, we have strived to address the
Figure 8. Phenotypic analysis of srs2 1-860 and srs2 875-902. (A) The
ability of the srs2 1–860 and srs2 D875–902 alleles to suppress the
MMS sensitivity of rad18D cells was examined. Platings on both
YPD and YPD containing 0.005% MMS are shown. (B) Rates of
recombination between the leu2-RI and leu2-bsteII alleles were deter-
mined and the results graphed. The rates shown represent the mean
from three independent ﬂuctuation tests performed for each strain.
Error bars are the standard deviations derived from this mean of
three independent rate determinations. Asterisks denote signiﬁcant
results, as determined by t-tests: **P < 0.005; *P < 0.05. Speciﬁcally,
the rates for SRS2 and srs2D875–902 are signiﬁcantly diﬀerent
(P=0.00004), the rates for SRS2 and srs2 D875–902 are marginally
diﬀerent (P=0.0117), and the rates for SRS2 and srs2 1–860 are
signiﬁcantly diﬀerent (P=0.0016).
Figure 7. Quantiﬁcation of Rad51 presynaptic ﬁlament disruption by
electron microscopy. (A) Representative Rad51 nucleoprotein ﬁlaments
(I) or RPA-ssDNA complexes (II) assembled on 150-mer ssDNA. The
scale bar represents 50nm. (B) Distribution of Rad51 presynaptic
ﬁlaments and RPA-ssDNA complexes observed following incubation
without or with 100nM Srs2, srs2 1–910, srs2 875–902 or srs2 1–875.
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biochemical level. Speciﬁcally, by a combination of yeast
two-hybrid analysis and biochemical mapping, we have
narrowed the Rad51 interaction domain to a short
region within the Srs2 C-terminus, and have taken advan-
tage of this information to generate several truncation
mutants of Srs2 that retain wild-type levels of ATPase
and helicase activities but are speciﬁcally compromised
for Rad51 interaction. Importantly, with both biochemi-
cal means and electron microscopy, we have demonstrated
a diminished ability of these srs2 mutants to attenuate
Rad51-mediated HR reactions and to dismantle the
Rad51 presynaptic ﬁlament, in concordance with the
degree of Rad51 interaction deﬁciency. We note that, by
employing a kinetic assay involving the use of a
ﬂuorescently labeled DNA substrate, Antony et al. (50)
also showed recently that the srs2 1–860 mutant is deﬁ-
cient in anti-recombinase activity. Thus, in aggregate, our
ﬁndings and those of Antony et al. (50) reveal that the
eﬃcacy of Srs2 as an anti-recombinase is dependent on
its physical interaction with Rad51. Consistent with our
biochemical results, we found that the srs2 1–860 mutant
displays a hyper-recombination phenotype. Since the srs2
1–860 mutant protein retains wild-type levels of ATPase
and helicase activities, our results thus provide evidence
that the Srs2 helicase domain alone is insuﬃcient for anti-
recombinase function in cells. We have shown that the srs2
875–902 mutant protein is less impaired for Rad51 inter-
action or for the ability to inhibit Rad51-mediated
reactions in vitro. The phenotype of srs2 D875–902 cells
is accordingly mild or near wild-type.
Like Srs2, the human RECQ5 helicase associated with
Rad51 physically, inhibits the Rad51-mediated D-loop
reaction, and catalyzes the removal of Rad51 from
ssDNA in a manner that is dependent on its ATPase
activity (43). Based on these functional similarities
between Srs2 and RECQ5, it seems reasonable to
suggest that Rad51 interaction is also a determinant of
the anti-recombinase activity of RECQ5. The results of
Antony et al. have suggested that Srs2 enhances ATP
hydrolysis by Rad51 within the presynaptic ﬁlament,
thereby hastening Rad51 dissociation from DNA (50). It
will be interesting to test whether RECQ5 also acts by a
similar mechanism.
We note that Srs2 becomes phosphorylated on multiple
sites in response to intra-S phase DNA damage (26), and
several of these phosphorylation sites are located within
the C-terminus of the protein, including two such sites in
the region spanning residues 875–902 (51) that we know
are important for complex formation with Rad51
(this work). It will be particularly interesting to ascertain
how C-terminal phosphorylation of Srs2 in response to
DNA damage regulates its anti-recombinase function via
an inﬂuence on complex formation with Rad51.
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